A randomized trial of ultrasound-facilitated, catheter-directed, thrombolysis versusanticoagulation for acute intermediate-high risk pulmonary embolism: The higher-riskpulmonary embolism thrombolysis study(HI-PEITHO)
Sponsor: |
Boston Scientific Corporation |
Enrolling: |
Male and Female Patients |
IRB Number: |
AAAT8152 |
U.S. Govt. ID: |
NCT04790370 |
Contact: |
Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu |
The purpose of this study is to determine whether treatment with anticoagulation medications incombination with the EkoSonicTM Endovascular device with a dose of a clot-dissolving drug(thrombolytic) can reduce the risk of death and other serious problems when compared to anticoagulation medication alone. Other measurements will be taken to observe your overall health and quality of life for one year after treatment.
Investigator
Sanjum Sethi, MD, MPH
Are you 18 years or older? |
Yes |
No |